Status:

COMPLETED

Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study

Lead Sponsor:

University of Minnesota

Conditions:

Pulmonary Arterial Hypertension

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

Brief Summary

This pilot clinical trial will evaluate the initial safety and feasibility of intestinal microbiota transplantation (IMT) in patients with pulmonary arterial hypertension (PAH). This trial will inform...

Detailed Description

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by pulmonary vascular remodeling of precapillary pulmonary arteries resulting in obstruction, increased pulmonary vascular resi...

Eligibility Criteria

Inclusion

  • Diagnosis of pulmonary arterial hypertension (PAH)
  • On stable treatment for PAH for one month prior to enrollment
  • Able to swallow capsultes
  • Able to provide blood sample and fecal sample

Exclusion

  • Dysphagia to pills
  • Clinically active inflammatory bowel disease
  • Pregnancy or breastfeeding
  • Life expectancy of \<6 months
  • Presence of ileostomy or colostomy
  • Taking immunosuppressants (calcineurin inhibitors, prednisone greater than or equal to 20mg/day, methotrexate, azathioprine, immunosuppressive biologics, JAK inhibitors)
  • Neurotropenia (an absolute neurotrophil count \< 0.5 x 10\^9 cells/L)
  • History of solid organ or bone marrow transplant
  • Anticipated recurrent antibiotic use (participants with frequent urinary tract infections or sinusitis)
  • History of severe anaphylactic food allergy
  • History of celiac disease
  • History of receiving cancer chemotherapy, immunotherapy, or radiation

Key Trial Info

Start Date :

November 3 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT04884971

Start Date

November 3 2021

End Date

December 31 2023

Last Update

February 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study | DecenTrialz